Is It Too Late to Buy Broadcom Stock?

Broadcom's AI semiconductor business generated $8.4 billion in fiscal Q1 2026, with management targeting over $100 billion in custom AI chip revenue by the end of 2027. Analysts expect total company revenue to rise from about $64 billion in fiscal 2025 to $159 billion by 2027, implying significant growth already priced into the stock. The article is constructive on Broadcom's long-term AI prospects but warns that the shares now trade at 86x trailing earnings and 39x forward earnings, limiting near-term upside if growth disappoints.

Analysis

AVGO is increasingly behaving like a long-duration AI infrastructure annuity, but the market is discounting a very smooth ramp. The key second-order effect is that custom silicon shifts pricing power away from generic accelerators and toward the architect-integrator layer; that benefits Broadcom if hyperscalers keep prioritizing unit economics over vendor optionality. The flip side is that the more these programs scale, the more customers will pressure Broadcom on take-rates and engineering economics, so future upside likely comes from mix and attach rates rather than just chip shipments.

The bigger competitive implication is for NVDA and the broader GPU ecosystem: custom ASIC adoption is not a binary replacement, but it can siphon lower-return inference and steady-state workloads first, which is where the volume math is most dangerous. That creates a second-order capex reallocation risk across the supply chain, especially for memory, packaging, and networking vendors that are implicitly relying on perpetual GPU intensity. If enterprise and sovereign AI buyers view TPU-style architectures as a template, the market may be underestimating how quickly spend fragments away from a single dominant compute stack.

From a risk perspective, the stock is vulnerable to any evidence that the 2026-2027 production curve slips by even one cycle, because the multiple is already anchored to an aggressive earnings bridge. The real hazard is not a demand collapse, but a delay: one missed tape-out or a softer hyperscaler budget season could compress the forward multiple before the revenue shows up. That makes the next two earnings prints and customer commentary more important than the long-term narrative.

Consensus appears to be treating Broadcom as a winner-take-most AI compounder, but the better read is that it is a high-quality beneficiary of a trend that is still being negotiated by customers. The market may be underpricing execution risk and overpricing the certainty of a 2027 revenue step-up. In our view, the setup is still constructive, but asymmetry is no longer as attractive as it was when the AI custom-chip story was earlier and less widely owned.

Key Decisions for Investors

• Trim AVGO into strength over the next 2-6 weeks; keep only a core position until the market gets confirmation that the 2026 production ramps are real, not just guided. Risk/reward is now skewed toward multiple compression if delivery slips, while upside likely requires perfect execution.
• Favor a relative-value pair: long AVGO / short a basket of higher-beta AI hardware beneficiaries only if you want pure AI exposure; otherwise consider long AVGO / short NVDA on a 3-6 month horizon as a hedge against custom silicon taking incremental share from GPU inference spend.
• Buy AVGO downside protection into the next earnings window: 1-2 quarter put spreads 5-10% out of the money. The premium is justified because the main risk is a timing miss, which can re-rate the stock before fundamentals catch up.
• Watch GOOGL as a second-order beneficiary and validation signal. If TPU economics remain strong and external customers follow, it supports the broader custom-ASIC thesis; if not, it increases the probability that AVGO's growth narrative is overstated.
• Avoid chasing the stock after large gap-ups; wait for post-print digestion or a broader AI hardware pullback. The optimal entry is on any evidence of sentiment reset, not on headline-driven momentum.